Log in
Enquire now
Mabylon

Mabylon

Mabylon is a developer of human-derived antibodies for allergy treatment founded in 2015.

OverviewStructured DataIssuesContributors

Contents

mabylon.com
Is a
Company
Company
Organization
Organization

Company attributes

Industry
Health technology
Health technology
Biotechnology
Biotechnology
Biomedical engineering
Biomedical engineering
CEO
‌
Alcide Barberis
Number of Employees (Ranges)
11 – 50
Email Address
info@mabylon.com
Founded Date
2015
Total Funding Amount (USD)
37,000,000
Latest Funding Round Date
August 12, 2025
Also Known As
Mabylon AG
Latest Funding Type
‌
Venture round
COO
‌
Tiziana Sonati
Country
Switzerland
Switzerland
Headquarters
Schlieren, Switzerland
Schlieren, Switzerland

Other attributes

Company Operating Status
Active
Latest Funding Round Amount (USD)
37,000,000
No article content yet.

Timeline

No Timeline data yet.

Funding Rounds

Products

Acquisitions

SBIR/STTR Awards

Patents

Further Resources

Title
Author
Link
Type
Date
No Further Resources data yet.

References

Find more companies like Mabylon

Use the Golden Query Tool to find similar companies in the same industry, location, or by any other field in the Knowledge Graph.
Open Query Tool
Access by API
Golden Query Tool
Golden logo

Company

  • Home
  • Pricing
  • Enterprise

Legal

  • Terms of Service
  • Enterprise Terms of Service
  • Privacy Policy

Help

  • Help center
  • API Documentation
  • Contact Us
By using this site, you agree to our Terms of Service.